ADHD risk may be linked to inflammation during pregnancy
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…
On Aug. 13, 2020, Royal Philips introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses,…
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
On Aug. 12, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to NS Pharma’s Viltepso…
On Aug. 12, 2020, Celdara Medical announced that the National Institute of Allergy and Infectious Diseases (NIAID) of…
On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
On Aug. 11, 2020, Hologic announced that it has validated use of its Aptima® and Panther Fusion® molecular…
On Aug. 11, 2020, Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as…
On Aug. 11, 2020, Bio-Techne announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds…
On Aug. 11, 2020, LabCorp announced details of a no charge antibody testing program in response to federal…
On Aug. 11, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…
On Aug. 10, 2020, Omeros reported the results of a compassionate-use study evaluating narsoplimab, Omerosメ investigational human monoclonal…
On Aug. 10, 2020, two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs)…
On Aug. 10, 2020, Gilead Sciences announced that it had submitted a New Drug Application (NDA) to the…
On Aug. 10, 2020, CBR by Generate Life Sciences, the world’s largest private newborn stem cell bank, and…
On Aug. 9, 2020, Intravacc announced that it had been awarded a contract with base and options that…
On Aug. 9, 2020, OpGen announced that it had commenced marketing and promotion, on a non-exclusive basis, of…
On Aug. 7, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Evrysdi (risdiplam) to treat patients…
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
On Aug. 7, 2020, Altimmune announced that it has completed enrollment in its Phase 1b clinical trial of…
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
On Aug. 6, 2020, the world’s first successfully cloned Przewalski’s horse was born in Texas at the veterinary…
On Aug. 6, 2020, researchers at the AIDS Institute, Department of Microbiology and State Key Laboratory of Emerging…
On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…
On Aug. 6, 2020, Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,…
On Aug. 5, 2020, AXIM Biotechnologies announced the development, patent filing and Emergency Use Approval (EUA) filing of…
On Aug. 5, 2020, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and…
On Aug. 5, 2020, Variation Biotechnologies, an Ottawa-based subsidiary of VBI Vaccines, announced that it had been awarded…